BAYZF BAYER AG
- 31.690
- -0.020-0.06%
BAYER AG News
Earnings Call Summary | BAYER AG(BAYZF.US) Q1 2024 Earnings Conference
The following is a summary of the Bayer AG (BAYZF) Q1 2024 Earnings Call Transcript:Financial Performance:Bayer reported Q1 sales of €13.8 billion, slightly lower than the previous year.Core earnings
Bayer Cut 1500 Jobs in Q1
Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update
By Helena Smolak Bayer plans to keep cutting jobs after it shed about 1,000 management positions in the first quarter as part of a push to run the group with fewer bosses. Bayer's Chief Executive Bi
Bayer's Agricultural Earnings Surprise -- Market Talk
0649 GMT - Bayer's first-quarter adjusted Ebitda came ahead of Jefferies' and market expectations driven by higher-than-expected earnings in its agricultural business, Jefferies analysts say in a note
Bayer Net Profit Falls on Lower Sales, Currency Headwinds
By Helena Smolak Bayer posted a fall in first-quarter net profit on declining sales across all segments as well as currency headwinds. The German pharmaceutical and agricultural company said Tuesday
Stocks to Watch Next Week: Burberry, Vodafone, BT and Walmart
Elanco Surges on Q1 Beat, Anticipated Product Launches
UPDATE 1-Singtel-owned Optus Names Broadband Network Boss Stephen Rue as New CEO
Regeneron Falls After Q1 Miss; Announces $3B Share Buybacks
Metagenomi, Moderna Terminate Gene Editing Collaboration
Industry Veteran Chris Turner Joins Pivot Bio as Chief Commercial Officer
Former Head of U.S. Crop Science at Bayer to bring extensive expertise to propel Pivot Bio into next phase of growth. ST. LOUIS and BERKELEY, Calif., May 1, 2024 /PRNewswire/ -- Pivot Bio, a leading
Bayer Expands Partnership With Huma: Digital Heart Risk Assessment Tool Expands to Saudi Arabia
Saudi launch aligns with Vision 2030 healthcare transformation strategy and highlights Huma and Bayer's commitments to advancing care delivery in the Kingdom RIYADH, Saudi Arabia, May 1, 2024 /PRNews
Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases
Evotec (EVT.F) said Tuesday its partnership with German pharmaceutical company Bayer (BAYN.F) will now focus on developing precision treatments for cardiovascular diseases. The life science company wi
Bayer AG's Dividend Analysis
BAYER AG To Go Ex-Dividend On April 29th, 2024 With 0.12138 USD Dividend Per Share
April 26th - $BAYER AG(BAYZF.US)$ is trading ex-dividend on April 29th, 2024. Shareholders of record on April 30th, 2024 will receive 0.12138 USD dividend per share on May 2nd, 2024. The ex-divide
Autoinjectors Market Size Is Set to Grow by USD 134.01 Billion From 2023-2027, AbbVie Inc., Amgen Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global autoinjectors market size is estimated to grow by USD 134014.58 million from 2023 to 2027, according to Technavio. The market is estimated ...
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Pet Medication Market was valued at USD 13.21
Non-Hodgkin Lymphoma Therapeutics Market Size Is Set to Grow by USD 5.42 Billion From 2023-2027, AstraZeneca Plc, Baxter International Inc. and Bayer AG, and More to Emerge as Some of the Key Vendors, Technavio
The global non-hodgkin lymphoma therapeutics market size is estimated to grow by USD 5427.51 mn from 2023 to 2027, according to Technavio. The market ...
Bayer Dethroned as Germany's Top Drugmaker
Bayer's Consumer-Healthcare Unit Remains Attractive Acquisition Target -- Market Talk
1401 GMT - Bayer's consumer-healthcare unit remains an attractive asset and its size and geographic footprint make it a good acquisition target should the German company decide to put it up for sale a
Analysis
Price Target
No Data
